BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 38316884)

  • 1. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
    Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
    Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in
    Xie T; Wang Q; Gao J; He K; Yu J
    Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
    Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
    Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
    Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
    Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
    Yu Y; Qian J; Shen L; Ji W; Lu S
    Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
    Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
    J Proteomics; 2024 May; 302():105201. PubMed ID: 38768894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions.
    Subirá D; Barriopedro F; Fernández J; Martínez R; Chara L; Castelao J; García E
    Clin Exp Metastasis; 2023 Dec; 40(6):505-515. PubMed ID: 37812366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Profile of Three Splicing Factors in Pleural Cells Based on the Underlying Etiology and Its Clinical Values in Patients with Pleural Effusion.
    Han AL; Kim HR; Choi KH; Ryu JW; Hwang KE; So HS; Park MC; Zhu M; Huang Y; Lee YJ; Park DS
    Transl Oncol; 2018 Feb; 11(1):147-156. PubMed ID: 29288986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural Effusion.
    Li P; Shi J; Zhou L; Wang B; Zhang LJ; Duan L; Hu Q; Zhou X; Yuan Y; Li D; Chen H; Zhao Q; Peng X; Chen W
    Front Microbiol; 2021; 12():620322. PubMed ID: 34163438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural effusion: tumor-host interactions unleashed.
    Stathopoulos GT; Kalomenidis I
    Am J Respir Crit Care Med; 2012 Sep; 186(6):487-92. PubMed ID: 22652027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.
    Niu Y; Zhou Q
    Cell Mol Life Sci; 2022 Mar; 79(4):194. PubMed ID: 35298721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphology of metastatic malignant peripheral nerve sheath tumour present in pleural fluid: Case study and literature review.
    Pan YC; Xu Y; Wang Q; Xian ZH; Zhang SH
    Cytopathology; 2024 May; 35(3):398-403. PubMed ID: 38441189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the UroVysion
    Rosolen DCB; Faria DK; Faria CS; Antonangelo L
    Cancer Med; 2018 May; 7(5):1967-1977. PubMed ID: 29577646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
    Luo P; Mao K; Xu J; Wu F; Wang X; Wang S; Zhou M; Duan L; Tan Q; Ma G; Yang G; Du R; Huang H; Huang Q; Li Y; Guo M; Jin Y
    J Extracell Vesicles; 2020 Jul; 9(1):1790158. PubMed ID: 32944177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive models of malignant transudative pleural effusions.
    Ferreiro L; Gude F; Toubes ME; Lama A; Suárez-Antelo J; San-José E; González-Barcala FJ; Golpe A; Álvarez-Dobaño JM; Rábade C; Rodríguez-Núñez N; Díaz-Louzao C; Valdés L
    J Thorac Dis; 2017 Jan; 9(1):106-116. PubMed ID: 28203412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the patient with pleural effusion.
    Rahman NM; Munavvar M
    Clin Med (Lond); 2009 Apr; 9(2):174-8. PubMed ID: 19435129
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting pleural fluid results .
    Mercer RM; Corcoran JP; Porcel JM; Rahman NM; Psallidas I
    Clin Med (Lond); 2019 May; 19(3):213-217. PubMed ID: 31092513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Myeloma: A Rare Presentation As Unilateral Pleural Effusion.
    Deshmukh K; Hatgoankar K; Pande M; Sabale P; Bankar NJ
    Cureus; 2024 Feb; 16(2):e54789. PubMed ID: 38529443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic analysis of pleural fluid cell blocks using relevant immunohistochemical markers in clinically suspicious cases of malignancy.
    Mathew JK; Rajan GN; Kunju AK
    Cytojournal; 2024; 21():8. PubMed ID: 38469399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driverless artificial intelligence framework for the identification of malignant pleural effusion.
    Li Y; Tian S; Huang Y; Dong W
    Transl Oncol; 2021 Jan; 14(1):100896. PubMed ID: 33045678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.